Precision Medicine in Oncology
Precision Medicine in Oncology: More Strategies for Identifying Patients Needed
Ulrik Lassen, MD, PhD, oncology professor at the University of Copenhagen, discusses the increasing value of precision medicine in oncology.
Learn More about Clinical Roles
Latest News

Suzy Soliman, PharmD, discusses why October 12 was chosen to recognize Women Pharmacist Day.
Just as vaccinations get under way in full force, a few indicators raise the question about whether the vaccine really is as well matched as was anticipated.
The PARP inhibitor received a Breakthrough Therapy Designation for metastatic castration-resistant prostate cancer based on data released from the GALAHAD study.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape. 
Two cell mutations have been linked to acute myeloid leukemia, but the reason for their cooperation has been unknown.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
The funding is awarded to health departments representing 57 geographic areas to expand treatment and prevention efforts for HIV/AIDS.
The black-white disparity in breast cancer mortality has remained stable since 2011 after widening over the past 3 decades.
FDA Approves New PrEP Drug
The FDA has approved emtricitabine 200 mg and tenofovir alafenamide 25 mg (Descovy, Gilead Sciences Inc.) as a second pre-exposure prophylaxis drug in at-risk adults and adolescents weighing at least 75 Ib.
Study offers a new perspective on the molecular events that may lead some individuals to develop multiple sclerosis.
+ Load More

Explore More About Skidki-na-vse

дапоксетин купить в украине в аптеке

Augmenter le potentiel